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Abstract
Estrogen depletion increases the risk of dyslipidemia by triggering higher
levels of total cholesterol (TC), triglyceride (TG), and low density lipoprotein (LDL)
besides depressed level of high density lipoprotein (HDL). This study was conducted
to investigate the potential of cocoa products to affect serum lipid profile in the
estrogen-deficient rats. Thirty adult female wistar rats were divided into five groups
i.e. four groups contained ovariectomized rats, and one group consisted of intact rats.
The test articles were all dissolved in olive oil and administered orally, comprising
of 1 g/kg body weight (BW) cocoa powder, 1 g/kg BW cocoa extract, 1 mg/kg BW
estradiol valerate, 10 ml/kg BW olive oil as carrier. Intact group was given drinking
water. After three-day administration, the rats were terminated and serum lipid profile
was observed. The trial obtained ethical approval from the Animal Care and Use
Committee, Veterinary Faculty, Airlangga University (Certificate No. 620-KE). The
result showed that carrier group developed higher LDL and lower HDL levels, as
well as greater LDL/HDL ratio compared to that of intact group. Estradiol valerate
group had significantly elevated TG level. Cocoa powder and cocoa extract groups
showed small and non-significant changes in TC, TG and HDL. Surprisingly, consump-
tion of cocoa extract that is rich in polyphenols had resulted highest mean of LDL
levels among other groups. It was hypothesized that polyphenol in cocoa extract
had affected expression of LDL receptors (LDLR) due to an antagonistic activity
against estrogen receptor alpha (ERá). To conclude, neither cocoa powder nor
cocoa extract exhibits significant estrogenic effect on the serum lipid profile of
estrogen-deficient rats.
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INTRODUCTION
Estrogen deficiency alters serum lipid
profile in menopausal women. The change
is marked with higher low density lipoprotein
(LDL) levels which increases the risk of
atherosclerosis (Anagnostis et al., 2015).
Estrogen replacement therapy has shown
some evidences in suppressing LDL levels
thus it is considered having cardioprotective
benefit (Escalante et al., 2017).
Interestingly, some of estrogen replacement
substances come from polyphenol classes.
Extensive studies have revealed estrogenic
properties of some polyphenols such as on
genistein in soybean, 8-prenylnaringenin
in hop seed, and resveratrol in grape (Michel
et al., 2013). Polyphenol is abundantly present
in cocoa bean. The cocoa polyphenol had
shown cardioprotective property by suppressing
inflammation and enhancing elasticity
of the vascular wall (Baba et al., 2007).
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Nevertheless, the effect of cocoa polyphenol
on serum lipid profile during estrogen defi-
ciency is less investigated.
In this study, cocoa was investigated
for its ability to substitute estrogen effect
on serum lipid profile. For this purpose,
female rats were used and the production
of endogenous estrogen was stopped by
means of ovariectomy which removes both
ovaries as the main sources of estrogen
hormone. The cocoa powder and extract
were used as the test articles to respectively
represent a low polyphenol and high polyphenol
intake. Following three-day administration,
the serum was analyzed for total cholesterol
(TC), triglyceride (TG), LDL, and high density
lipoprotein (HDL) levels.
MATERIALS AND METHODS
Two products of cocoa were used in
the study which were cocoa powder and
cocoa extract. Cocoa powder was prepared
from dried cocoa beans that were roasted,
cleaned from shells, and separated from the
fat. Dried cocoa beans were from forastero
variety, collected from farmers around
Jember region. Cocoa extract was prepared
from fresh beans that were dried, cleaned
from shells, separated from the fat and
macerated in ethanol. The liquid extract was
spray-dried to result powdered extract. The
positive control was using estradiol valerate
(Progynova, Bayer) which is a synthetical
estrogen substitute. All test articles were
dissolved in olive oil as carrier, at concen-
tration 0.1g/mL.
Thirty wistar rats aged eight weeks old
were acclimatized for at least one week and
were distributed into five groups. Four
groups consisted of ovariectomized rats,
each group was constituted of 6 individuals.
The procedure for ovariectomy was initiated
with anesthesia done through intramuscular
injection of 0.1 mL ketamine and 0.1 mL
xylazine per individual (BW 60-80 g). After
removal of both ovaries, rats were allowed to
recover for two weeks prior to treatment.
One group of six intact rats was prepared
as control that represented normal estrogen
condition. To this group, the similar procedure
was performed but no tissue was removed.
During the trial period, rats were given free
access towards soy-free feed and water.
The ovariectomized rats received test
articles dissolved in olive oil. Test articles
consisted of cocoa powder 1 g/kg BW, cocoa
extract 1 g/kg BW, olive oil as carrier 1 mL/
kg BW, or estradiol valerate 1 mg/kg BW.
The intact rats received water 1 mL/kg BW.
Administration of test articles was through
oral route, once daily for three days. On the
fourth day, rats were terminated then the
blood samples were collected. The analysis
of serum lipid comprised of TC, TG, HDL,
and LDL levels measurement done by using
spectrophotometer. The atherogenic risk
predictors were calculated from the ratio of
HDL on TC, LDL on HDL, and log of (TG/
HDL) (Adejor et al., 2017).
Data from each group were the mean
from six replications. The data were tested
for normality distribution using Saphiro-Wilk
test, and transformed into log 10. The analysis
of covariance was performed at level of
confidence 95% ( = 0.05). Body weight
was included as the covariable.
RESULTS AND DISCUSSION
There were no significant changes in
the serum lipid profile in the two weeks post-
surgery. This is shown in the carrier group
and in the intact group (Figure 1). How-
ever, carrier group had slightly lower mean
HDL, and higher TC, TG, and LDL levels
than intact group. Estrogen substitution with
estradiol valerate for three days on the ova-
riectomized rats resulted no difference in the
TC, HDL and LDL levels, compared to two
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former groups. The LDL level tended to
decline but the change did not reach statis-
tical significance. TG level in the estradiol
valerate group was the highest among other
groups.
Cocoa powder group and cocoa ex-
tract group obtained some changes which
were not significantly different from the
carrier group. Both groups showed lower
TG, along with elevated TC and HDL levels.
LDL levels in the cocoa extract group were
significantly higher than any other groups.
The atherogenic risk predictors com-
prising of HDL/TC, LDL/HDL, and Log
(TG/HDL) (Figure 2) showed that all
ovariectomized rats developed higher
atherogenic risk. These are particularly
shown from significantly higher LDL/
HDL ratio (P<0.05) than intact group.
This finding confirms the cardiprotective
property carried out by estrogen.
Slight differences in the lipid profile of
the carrier group as compared to intact group
showed that the changes take certain time
after ovariectomy procedure. However, the
carrier group had higher LDL/HDL ratio,
which implies dyslipidemia was progress-
ing. It was reported that ovariectomized rats
developed dyslipidemia after 12 weeks post-
surgery (Saengsirisuwan et al., 2009). Simi-
larly, a very short-term administration of
estrogen substitute may not be sufficient to
improve serum lipid profile. Therefore, small
changes among groups were not surprising
within the time frame given in this trial.
The elevated TG level during the use of
estradiol valerate was also reported in other
study (Mvondo et al., 2011). Oral administration
Figure 1. Serum lipid profile of ovariectomized rats given cocoa powder (CP), cocoa extract (CE), estradiol
valerate (EV) and olive oil (carrier), compared with intact rats given drinking water (Intact).
The bar showed mean of total cholesterol (TC), triglyceride (TG), high density lipoprotein
(HDL), and low density lipoprotein (LDL) levels of each group.
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of estrogen therapy increased TG level, while
the transdermal administration did not (Crook
et al., 1992; Godsland, 2001). Exogenous
estrogen has been reported to decrease
activity of hepatic lipase which is respon-
sible for TG clearance from blood, thus serum
TG levels remained high (Godsland, 2001;
Tikkanen et al., 1979; Urabe et al., 1996).
Estrogen maintains circulating LDL
level by upregulating the expression of LDL
receptor (LDLR) whose one of its functions
is clearing LDL molecules from blood (Ohlsson
et al., 2000). In a cell based study, Smith
et al. (2004) reported that LDLR mRNA
was suppressed in the absence of estrogen,
and abundantly present after treatment with
17-ethinyl estradiol, while diminishing
dramatically following exposure of anti-
estrogen ICI 182,780. Its regulation specifi-
cally involves estrogen receptor alpha (ER),
of which one of the mechanisms is through
the interaction with steroid receptor binding
protein. It has been reported in several studies
that diarylpropionitrile, a specific ER agonist,
failed to suppress LDL level elevation in
estrogen-deficient animals (Xu et al.,
2016).
Cocoa is a great source of polyphenols,
mainly from a class of flavonoid. It has been
attributed with cardioprotective property. The
mechanisms are through improvement of
cardiovascular elasticity and inhibition of LDL
oxidation (Keen et al., 2005). Some studies
revealed that consumption of cocoa products
also decreased blood LDL levels, but this
was found in healthy individuals after long
term application (Jia et al., 2010). There is little
information on effect of cocoa consump-
tion in relation with estrogen status, such
as in perimenopausal and menopausal phases.
In this study using estrogen-deficient rats,
a significant rise in the LDL levels was
observed in the cocoa extract group (Figure 1).
The levels are the highest among all ovariec-
tomized groups, which indicated severe
LDLR obstruction. Apart from its antioxidative
and cardioprotective properties, the polyphenol-
rich cocoa extract may exhibit antagonistic
activity towards ER.
Figure 2. Atherogenic risk predictors in the ovariectomized rats given cocoa powder (CP), cocoa extract
(CE), estradiol valerate (EV) and olive oil (carrier), compared with intact rats given drinking
water (Intact). The bars show mean values of HDL/LDL, HDL/TC, and Log (TG/HDL) of
each group
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Polyphenol in the cocoa extract may
have also affected thyroid hormone levels.
Thyroid hormones reduce LDL level, not by
increasing expression of LDLR but by sup-
pressing production of apolipoprotein B
(Goldberg et al., 2012). There have been studies
on the inhibitory activity of polyphenols
against triiodothyronine (T3) and thyroxine
(T4) productions. For instance, green tea
polyphenols was reported to inhibit thyroid
peroxidase and thyroidal 5’-deiodinase I, the
enzymes that induce synthesis of both T3
and T4 (Chandra & De, 2013).
Thyroid and estrogen signaling both
have genomic and non-genomic pathways.
The genomic pathway involves nuclear
receptors, while non-genomic one interacts
with membrane receptors. The non-genomic
pathway of thyroid and estrogen hormones
is overlapping. When thyroid hormone binds
to its membrane receptor, signal transduc-
tion is induced. The intermediate proteins
playing role in signal transduction, for instance
mitogen activated protein kinase (MAPK),
are then able to activate ER (Davis et al.,
2011) which is responsible for triggering
expression of LDLR (Li et al., 2001). In the
case of high serum LDL levels in the cocoa
extract group, it is hypothesized that polyphenol
in the cocoa extract had decreased thyroid
hormones level. This event along with the
lack of estrogen following ovariectomized,
suppresses activation of ER and conse-
quently LDLR expression, leading to high
LDL level in serum. Future study should
investigate the influence of cocoa polyphenol
towards ERá via thyroid hormone pathway.
CONCLUSIONS
Cocoa powder and cocoa extract failed
to substitute estrogen in improving serum
lipid profile of estrogen deficient rats. Ova-
riectomized rats consuming both test articles
did not experience significant increase in HDL
nor decrease in TG and TC, as compared
with ovariectomized rats consuming olive
oil as carrier. Cocoa extract group developed
high LDL level after treatment, suggesting
antagonistic activity against ER.
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